510(k) for Mallinckrodt's ventilator system:
This article was originally published in Clinica
Executive Summary
Mallinckrodt's respiratory group Nellcor Puritan Bennett has received US clearance for its 840 ventilator system. The lightweight, compact system is designed for breath delivery to critically ill infant, paediatric and adult patients. It consists of touch screen monitors which allows the clinician to set up and preview proposed ventilator and alarm limit settings before applying to the patient, and a backup power source which provides 30 minutes of back-up power.
You may also be interested in...
At-Home Health Testing Demand Is High Post-Pandemic, But So Are Barriers To Development And Use
At the recent Precision Med-Tri Con conference, laboratory experts traded views on the expansion of at-home testing for disease diagnosis and personalized health insights. While strong consumer demand spells opportunity, there are significant concerns about the accuracy and reliability of home-testing platforms, misuse, accessibility, and lack of health literacy.
Simplified Clinical Trial Transparency Rules To Go Live In The EU In June
A new version of the EU Clinical Trials Information System’s public portal will integrate the functionalities of the streamlined transparency rules.
Top-Selling Drugs 2023: Pharma’s $60bn COVID-19 Cliff
Pfizer/BioNTech’s COVID-19 vaccine Comirnaty toppled after recording the highest ever annual sales for a pharmaceutical in 2022, while Novo Nordisk’s Ozempic climbed rapidly. But Merck & Co’s immuno-oncology blockbuster Keytruda was secure in the number one spot in 2023 as COVID-19 receded.